Cargando…
The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045005/ http://dx.doi.org/10.1186/1742-4690-11-S1-O2 |
_version_ | 1782319235929735168 |
---|---|
author | Suehiro, Youko Hasegawa, Atsuhiko Iino, Tadafumi Sasada, Amane Watanabe, Nobukazu Choi, Ilseung Fukuda, Tetsuya Takaishi, Shigeo Tanosaki, Ryuji Utsunomiya, Atae Miura, Osamu Matsuoka, Masao Teshima, Takanori Akashi, Koichi Okamura, Jun Kannagi, Mari Uike, Naokuni |
author_facet | Suehiro, Youko Hasegawa, Atsuhiko Iino, Tadafumi Sasada, Amane Watanabe, Nobukazu Choi, Ilseung Fukuda, Tetsuya Takaishi, Shigeo Tanosaki, Ryuji Utsunomiya, Atae Miura, Osamu Matsuoka, Masao Teshima, Takanori Akashi, Koichi Okamura, Jun Kannagi, Mari Uike, Naokuni |
author_sort | Suehiro, Youko |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4045005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40450052014-06-19 The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes Suehiro, Youko Hasegawa, Atsuhiko Iino, Tadafumi Sasada, Amane Watanabe, Nobukazu Choi, Ilseung Fukuda, Tetsuya Takaishi, Shigeo Tanosaki, Ryuji Utsunomiya, Atae Miura, Osamu Matsuoka, Masao Teshima, Takanori Akashi, Koichi Okamura, Jun Kannagi, Mari Uike, Naokuni Retrovirology Oral Presentation BioMed Central 2014-01-07 /pmc/articles/PMC4045005/ http://dx.doi.org/10.1186/1742-4690-11-S1-O2 Text en Copyright © 2014 Suehiro et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Suehiro, Youko Hasegawa, Atsuhiko Iino, Tadafumi Sasada, Amane Watanabe, Nobukazu Choi, Ilseung Fukuda, Tetsuya Takaishi, Shigeo Tanosaki, Ryuji Utsunomiya, Atae Miura, Osamu Matsuoka, Masao Teshima, Takanori Akashi, Koichi Okamura, Jun Kannagi, Mari Uike, Naokuni The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title | The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title_full | The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title_fullStr | The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title_full_unstemmed | The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title_short | The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes |
title_sort | phase-i study of a therapeutic vaccine to atl patients with autologous dendritic cells pulsed with peptides corresponding to tax-specific ctl epitopes |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045005/ http://dx.doi.org/10.1186/1742-4690-11-S1-O2 |
work_keys_str_mv | AT suehiroyouko thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT hasegawaatsuhiko thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT iinotadafumi thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT sasadaamane thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT watanabenobukazu thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT choiilseung thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT fukudatetsuya thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT takaishishigeo thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT tanosakiryuji thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT utsunomiyaatae thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT miuraosamu thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT matsuokamasao thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT teshimatakanori thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT akashikoichi thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT okamurajun thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT kannagimari thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT uikenaokuni thephaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT suehiroyouko phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT hasegawaatsuhiko phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT iinotadafumi phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT sasadaamane phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT watanabenobukazu phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT choiilseung phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT fukudatetsuya phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT takaishishigeo phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT tanosakiryuji phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT utsunomiyaatae phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT miuraosamu phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT matsuokamasao phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT teshimatakanori phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT akashikoichi phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT okamurajun phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT kannagimari phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes AT uikenaokuni phaseistudyofatherapeuticvaccinetoatlpatientswithautologousdendriticcellspulsedwithpeptidescorrespondingtotaxspecificctlepitopes |